Art

J-GLOBAL ID：202002213446521636   Reference number：20A0665749

Posttransplantation Lymphoproliferative Disease Treated by Retransplantation

再移植により治療した移植後リンパ増殖性疾患【JST・京大機械翻訳】

Author (8)： Weum Abrahamsen Ingerid ( Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway) ,  Gronvold Bjorn Christer ( Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway) ,  Inderberg Else Marit ( Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway) ,  Mensali Nadia ( Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway) ,  Mattsson Jonas ( Institute of Clinical Medicine, University of Oslo, Oslo, Norway) ,  Mattsson Jonas ( Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada) ,  Gedde-Dahl Tobias ( Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway) ,  Gedde-Dahl Tobias ( Institute of Clinical Medicine, University of Oslo, Oslo, Norway)
Material： Case Reports in Immunology (Web)
Volume： 2020  Page： Null  Publication year： 2020 
JST Material Number： U7844A  ISSN： 2090-6609  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Epstein-Barr virus- (EBV-) ind...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0665749&from=J-GLOBAL&jstjournalNo=U7844A") }}

Thesaurus term： GVH disease ,  stem cell ,  complication ,  *replantation ,  prevention ,  case report ,  hematopoietic stem cell ,  donor ,  T cell ,  risk factor ,  DNA ,  aplastic anemia ,  single administration
Semi thesaurus term： リツキシマブ ,  同種造血幹細胞移植 , 【Automatic Indexing@JST】

JST classification (5)： Treatment for infectious diseases,parasitic diseases.  (GD01030D) ,  Immunologic diseases,allergic diseases in general.  (GD04010C) ,  Treatment for hematologic diseases in general  (GK05010E) ,  Blood cell tumors(=neoplasms)  (GK04000M) ,  Hematologic diseases  (GK03000F)

Reference (14)：

• M. Uhlin, H. Wikell, M. Sundin et al., "Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation," Haematologica, vol. 99, no. 2, pp. 346-352, 2014.
• R. Admiraal, S. Nierkens, M. A. de Witte et al., "Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis," The Lancet Haematology, vol. 4, no. 4, pp. e183-e191, 2017.
• R. Storb, W. Leisenring, C. Anasetti et al., "Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin," Blood, vol. 89, no. 10, pp. 3890, 1997.
• E. Carreras, C. Dufour, M. Mohty, N. Kröger, The EBMT Handbook, Springer, Berlin, Germany, 2019.
• I. García-Cadenas, L. Yáñez, I. Jarque et al., "Frequency, characteristics, and outcome of PTLD after allo-SCT: a multicenter study from the Spanish group of blood and marrow transplantation (GETH)," European Journal of Haematology, vol. 102, no. 6, pp. 465-471, 2019.

Terms in the title (3)： 再移植 ,  治療 ,  移植後リンパ増殖性疾患